Hartford Hospital
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Hartford Hospital sits in the top decile of US sponsors by registered trial count (#290 of 15,742 sponsors by registered trial count).
Hartford Hospital: 75 sponsored US clinical trials, 8 recruiting.
Hartford Hospital sponsors 75 registered US clinical trials on ClinicalTrials.gov, 8 of them currently recruiting, and 56 completed. 15 of these trials are in Phase 3-4 (later-stage) and 17 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 3 trials.
Top-decile sponsor footprint
Hartford Hospital ranks in the top decile of sponsors by registered trial count (#290 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
56 of 61 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (91.8%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
75 total, page 1 of 2
Motivating Increases in Physical Activity for Prevention of Weight Regain After Metabolic Bariatric Surgery
NCT06484621
Improving Availability of Intranasal Naloxone
NCT05877118
Tai Chi as a Novel Strategy to Increase Physical Activity Among Adults Pursuing Metabolic and Bariatric Surgery
NCT06445413
Multifidus Cervicis Plane Block Vs. Sham Block For Posterior Cervical Spine Fusion Surgery
NCT05996133
Etomidate Versus Propofol in CABG Surgery
NCT06068764
Target ADHD Executive Working Memory Replication Study
NCT06446284
Liposomal Bupivacaine/Bupivacaine in Rectus Sheath Blocks Versus Ropivacaine in Rectus Sheath Blocks And Catheters
NCT05972018
Bilateral TAP and RS Blocks Using Liposomal Bupivacaine/Bupivacaine vs. Regular Bupivacaine in Laparoscopic Colectomy
NCT05224089
Use of Artificial Intelligence by Urogynecologic Patients
NCT06481436
THC Memory & Reward Learning Pilot
NCT05116527
Hippocampal Response to Acute Oral Doses of CBD During an fMRI Memory Task
NCT04778644
Neuroimaging Predictors of Bariatric Surgical Outcome
NCT03582748
Testing a Brief Exercise Intervention in Hoarding Disorder
NCT06561659
DePuy Synthes Variable Angle LCP Patella Plating System Study
NCT05824676
Imipenem/Cilastatin/Relebactam Pharmacokinetics, Safety, and Outcomes in Adults and Adolescents With Cystic Fibrosis
NCT05561764
A Feasibility Open Trial of App-Enhanced Brief CBT for Suicidal Inpatients
NCT05486091
Cefiderocol Plasma Concentrations in Patients Receiving Renal Replacement Therapy
NCT05373615
Cefiderocol Pharmacokinetics in Adult Patients With Cystic Fibrosis
NCT05314764
Bioavailability of Tebipenem (SPR994) Crushed Tablet
NCT05296382
Preoperative Acupuncture for Total Knee or Hip Arthroplasty
NCT06099223
Target ADHD Executive Working Memory Study
NCT04795674
Mobile Technology for Reducing and Preventing Adolescent Suicide
NCT04896593
Tebipenem (SPR994) Tissue Penetration in Diabetic Patients With Wound Infections and Healthy Volunteers Via In Vivo Microdialysis
NCT04919954
Imipenem-Relebactam Pharmacokinetics in Augmented Renal Clearance
NCT04147221
Omadacycline Tissue Penetration in Diabetic Patients With Wound Infections and Healthy Volunteers Via In Vivo Microdialysis
NCT04144374
Inpatient Cognitive-Behavioral Therapy to Reduce Suicide Risk Post-Discharge
NCT04168645
Vaginal Probiotics and Pessaries and Their Impact on the Vaginal Microenvironment
NCT04118049
What is the Impact of the Presence of a Support Person on Informed Consent
NCT03966469
LIBERATE - LIposomal Bupivacaine vERsus Adjuncts in Total shouldErs
NCT03887650
Efficacy of Pharmacotherapy to Enhance Weight Loss Following Sleeve Gastrectomy
NCT03603080
Enhanced Recovery After Surgery in Laparoscopic Sleeve Gastrectomy
NCT03520803
Peritoneal Iliac Flap and Lymphocele Formation After Robotic Radical Prostatectomy
NCT03567525
Can DFN-15 Terminate Migraine With Allodynia?
NCT03472378
Neurofeedback Training for High Risk Psychosis
NCT03447548
An Initial Feasibility Study of Brief Cognitive Behavioral Therapy for Suicidal Inpatients
NCT03442699
Catheter Management After Pelvic Reconstructive Surgery
NCT03071211
Tedizolid Tissue Penetration in Diabetic Patients With Wound Infections and Healthy Volunteers Via In Vivo Microdialysis
NCT02620787
Tissue Penetration of Ceftolozane/Tazobactam in Diabetic Patients With Lower Limb Infections
NCT02620774
Overactive Bladder Education
NCT02505607
Phenazopyridine for Confirmation of Ureteral Patency
NCT02424149
Timing of Pessary Care
NCT02371083
Transcranial Magnetic Stimulation Treatment of Hoarding Disorder
NCT02236767
Transcranial Magnetic Stimulation Treatment for Generalized Anxiety Disorder
NCT01815099
Decreasing Narcotics in Advanced Pelvic Surgery
NCT02110719
Contingency Management for Hoarding Disorder
NCT04894851
Neural Mechanisms of CBT Response in Hoarding Disorder
NCT01956344
Study to Assess Inhibition of Spore Production in Patients With C. Difficile Infections: Fidaxomicin Versus Vancomycin
NCT01818141
Effectiveness and Neuropsychological Predictors of Guided Self-Help for Obsessive-Compulsive Disorder (OCD)
NCT01659125
Locating Regions of Interest in Generalized Anxiety Disorder Using Function Magnetic Resonance Imaging (fMRI)
NCT01607710
Transcranial Magnetic Stimulation Treatment for Generalized Anxiety Disorder
NCT01659736
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 12 |
| Phase 2 | 5 |
| Phase 3 | 1 |
| Phase 4 | 14 |
What is open in the Hartford Hospital pipeline
8 recruiting of 75 indexed (11% open); 56 completed (75%).
Phase mix: 15 late (III/IV) vs 17 early (I/II) (balanced across stages).
Top condition: Obesity (3 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Hartford Hospital: open-pipeline peers nationwide
Peers matched on 75 registered trials and 11% open enrollment, not the therapeutic-area sidebar.
Hartford Hospital sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 75 trials (± recruiting share)
- C. R. Bard · 75 trials · 5% recruiting
- ECOG-ACRIN Cancer Research Group · 75 trials · 16% recruiting
- Inova Health Care Services · 75 trials · 29% recruiting
- Ionis Pharmaceuticals · 76 trials · 12% recruiting
Sponsors near 11% open enrollment (± trial volume)
- UConn Health · 11% recruiting · 178 trials
- Tufts Medical Center · 11% recruiting · 169 trials
- CAMC Health System · 11% recruiting · 28 trials
- Bastyr University · 11% recruiting · 19 trials
Related
What to do with this Hartford Hospital page
75 registered trials is a research-attention snapshot, not an endorsement of Hartford Hospital or any single study.
- 8 of Hartford Hospital's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition Hartford Hospital studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Hartford Hospital pipeline card: 75 registered trials from official public datasets.Report a data error.